Related Experiment Videos
Oncogenic mutations of alpha-Gi2 protein are not determinant for human adrenocortical tumourigenesis
1Laboratoire d'Explorations Fonctionnelles Endocriniennes, Hôpital Trousseau, Paris, France.
Abstract:
Activating mutations of G proteins, which are membrane signal transducers, have been associated recently with the development of various endocrine neoplasms. Mutations of two highly conserved codons, Arg201 and Gln227, in the alpha-subunit of the Gs protein, the adenylyl cyclase-stimulating protein, were first described in growth hormone-producing pituitary tumours. They resulted in constitutive activation of the alpha s-subunit by decreasing intrinsic GTPase activity. A similar mutation, affecting codon Arg179 (exon 5) in the alpha-subunit of the Gi2 protein, the adenylyl cyclase-inhibiting protein, has been described by a single group in ovarian and adrenocortical tumours. We evaluated the frequency of activating mutations in the alpha-subunit of the Gi2 protein in 18 human adrenocortical tumours. We screened exons 5 (codon Arg179) and 6 (codon gln205) for mutations by denaturing gradient gel electrophoresis analysis of leucocyte and tumoural DNA. No abnormal migration pattern was found in either exon. The absence of mutation in exon 5, which includes the Arg179 codon, was confirmed in all tumoural DNA by direct sequencing. In conclusion, we did not find any oncogenic mutations in the GTPase domain of the alpha-subunit of the Gi2 protein in adrenocortical tumours. Thus, the previously oncogenic gip2 mutations do not appear to be determinant for adrenocortical tumourigenesis.
Insights
Activating mutations in the Gi2 protein alpha-subunit were investigated in adrenocortical tumors. Researchers found no evidence that these specific G protein mutations drive tumor development in the adrenal cortex.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Activating mutations in G proteins are linked to endocrine neoplasms.
- Specific mutations in Gs protein alpha-subunit are found in pituitary tumors.
- Gi2 protein alpha-subunit mutations have been implicated in ovarian and adrenocortical tumors.
Purpose of the Study:
- To determine the frequency of activating mutations in the Gi2 protein alpha-subunit in human adrenocortical tumors.
- To investigate the role of specific codons (Arg179 and Gln205) in Gi2 protein alpha-subunit mutations in adrenocortical tumorigenesis.
Main Methods:
- Screening of exons 5 and 6 of the Gi2 protein alpha-subunit for mutations using denaturing gradient gel electrophoresis (DGGE).
- Analysis of DNA from 18 human adrenocortical tumors and patient leukocytes.
- Confirmation of mutation absence by direct sequencing of tumor DNA.
Main Results:
- No abnormal migration patterns were detected in exons 5 or 6 via DGGE.
- Direct sequencing confirmed the absence of mutations in the Arg179 codon (exon 5) in all analyzed tumor DNA.
- The study found no evidence of activating mutations in the GTPase domain of the Gi2 protein alpha-subunit in the evaluated adrenocortical tumors.
Conclusions:
- The study did not identify oncogenic mutations in the GTPase domain of the Gi2 protein alpha-subunit in human adrenocortical tumors.
- Previously reported oncogenic Gi2 protein mutations do not appear to be a determining factor in adrenocortical tumor development.
- Further research may be needed to explore other genetic alterations involved in adrenocortical tumorigenesis.